AzTrials
AzTrials

DeQuervain TendinopathyNCT07587489

Graston Technique and Myofascial Release in De Quervain's Tenosynovitis

A study testing Graston Technique and Myofacial Release Therapy in people with DeQuervain Tendinopathy and DeQuervain's Tenosynovitis, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research compares how well the Graston Technique and Myofascial Release Therapy work to reduce pain and improve flexibility for those struggling with De Quervain's tenosynovitis Read more about this study

Who is it for?
Ages 21 to 50 years
What is being tested?
Graston Technique and Myofacial Release Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 sitePakistan
Study dates
1 Aug 2025to 30 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age group of twenty one to fifty years
  • individuals having positive test for dequervains tenosynovitis
  • pain > 6 weeks

Who cannot join

  • arthritis
  • any neurological syndrome of hand
  • any pathology of hand skeletal structure
  • any surgery
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Elite College of Management Sciences, Gujranwala

    Gujranwala, Punjab Province

Other trials in Pakistan

About this study

Official title: Effects of Graston Technique and Myofascial Release in De Quervain's Tenosynovitis

This research compares how well the Graston Technique and Myofascial Release Therapy work to reduce pain and improve flexibility for those struggling with De Quervain's tenosynovitis

Read the detailed description

This randomized trial compared the Graston Technique against Myofascial Release in 32 patients with De Quervain's tenosynovitis. Participants were randomly split into two groups of 16, with both receiving baseline ultrasound and exercise therapy. Over four weeks (eight sessions total), outcomes were evaluated using the Numeric Pain Rating Scale, the DASH questionnaire, and goniometer measurements to determine the impact on pain and range of motion.

Being tested
Graston Technique, Myofacial Release Therapy
Keywords
De Quervain's Tenosynovitis, Graston technique, myofascial release, wrist pain
Medical subject headings
De Quervain Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Graston TechniqueOther

    Use of IASTM Tool to treat Dequervains Tenosynovitis. 2 sessions per week were administered along with conventional physical therapy.

  • Myofacial Release TherapyOther

    Use of Myofascial release therapy to treat Dequervains Tenosynovitis. 2 sessions per week were administered along with conventional physical therapy.

Study groups in NCT07587489
Study groupRoleWhat they receive
Graston TechniqueExperimentalthis experimental groups was treated with Graston technique for Dequervains Tenosynovitis
Receives: Other: Graston Technique
Myofacial Release TherapyExperimentalthis experimental groups was treated with Myofacial Release therapy for Dequervains Tenosynovitis
Receives: Other: Myofacial Release Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numerical Pain Rating Scale

    Numeric Pain Rating Scale is a tool used to report pain and has a scale or 0 to 10 in which 0 means no pain and 10 means extreme pain.

    Measured: 4 weeks

  2. Disabilities of the Arm, Shoulder and Hand Questionnaire

    It is used to measure how a person's upper-limb issues affect their daily life. A score of 0 represents no disability. A score of 100 represents extreme disability.

    Measured: 4 weeks

Secondary outcomes (1)
  1. Range of Motion

    Goniometry is used to measure improvement in joint Range of Motion of hand.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2026
  2. Study start1 Aug 2025
  3. Primary completion10 Apr 2026
  4. Study completion30 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07587489
Sponsor's protocol ID
2021-066493
Status last verified
May 2026
First submitted
8 May 2026
Last updated
19 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ali M, Asim M, Danish SH, Ahmad F, Iqbal A, Hasan SD. Frequency of De Quervain's tenosynovitis and its association with SMS texting. Muscles Ligaments Tendons J. 2014 May 8;4(1):74-8. eCollection 2014 Jan.

    PubMed 24932451
  • Alduqsi, B. (2024). An exploration of the use of Kinesio taping, long thumb spica orthosis (splint) and corticosteroid injections as a nonsurgical approach for treating DeQuervain's tenosynovitis.

  • Ajimsha MS, Al-Mudahka NR, Al-Madzhar JA. Effectiveness of myofascial release: systematic review of randomized controlled trials. J Bodyw Mov Ther. 2015 Jan;19(1):102-12. doi: 10.1016/j.jbmt.2014.06.001. Epub 2014 Jun 13.

    PubMed 25603749
  • Ahuja NK, Chung KC. Fritz de Quervain, MD (1868-1940): stenosing tendovaginitis at the radial styloid process. J Hand Surg Am. 2004 Nov;29(6):1164-70. doi: 10.1016/j.jhsa.2004.05.019.

    PubMed 15576233
  • Dundar Ahi E, Sirzai H. Short-term Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis: A Prospective, Randomized, Controlled Study. Medeni Med J. 2023 Mar 28;38(1):24-31. doi: 10.4274/MMJ.galenos.2023.67279.

    PubMed 36974441

Questions about this trial

What is this clinical trial studying?

A study testing Graston Technique and Myofacial Release Therapy in people with DeQuervain Tendinopathy and DeQuervain's Tenosynovitis, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numerical Pain Rating Scale (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07587489, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in